Search Results 371-380 of 3082 for Mão Morta de Volkmann

  1. A Study of the Quantiferon CMV Blood Test to Predict the Risk of CMV Returning After Treatment of the Disease in Solid Organ Transplant Recipients - Mayo Clinic

    The overall aim of this study is to determine whether solid organ transplant recipients who develop immunity to cytomegalovirus (CMV) after an initial episode ...

  2. Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia - Mayo Clinic

    This open-label study is to determine the safety and efficacy of momelotinib in participants with either polycythemia vera (PV) or essential thrombocythemia (ET) ...

  3. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

  4. https://www.mayoclinic.org/spanish_condition_consolidated_concepts.xml

  5. https://www.mayoclinic.org/chinese_condition_consolidated_concepts.xml

  6. Multiple Myeloma Clinical Trials - Mayo Clinic Research

    The primary objectgive of this study is to determine the effectiveness of SAR442168 compared to placebo in delaying disability progression in primary ...

  7. Luis Lujan, Ph.D., M.S. - Mayo Clinic Faculty Profiles

    SUMMARY. Deep brain stimulation (DBS) is an effective electrical stimulation technique for treating patients with certain types of neurological disorders ...

  8. Pulmonary Hypertension Association Registry - Mayo Clinic

    About this study. The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic ...

  9. A Study of the Relationship Between Infliximab Levels and the Rate of Colectomies in Patients who have Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to assess if infliximab drug levels in patients who have Ulcerative Colitis predict the risk of needing a colectomy. Additionally, ...

  10. A Study to Evaluate Precision Pharmacogenomics in Cancer Patients - Mayo Clinic

    THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a cohort of cancer ...